Skip to main content
Epigenomics AG logo

Epigenomics AG — Investor Relations & Filings

Ticker · ECX ISIN · DE000A37FT41 LEI · 549300X1C4U862NDLN97 F Financial and insurance activities
Filings indexed 90 across all filing types
Latest filing 2013-10-24 Audit Report / Informat…
Country DE Germany
Listing F ECX

About Epigenomics AG

https://www.epigenomics.com/

Epigenomics AG operates as a holding company dedicated to managing its assets and investments. The company's primary investment focus is on the field of molecular diagnostics, particularly in companies developing minimally invasive, blood-based tests for the early detection of cancer. This strategy leverages the company's historical expertise in the development of in vitro diagnostic products based on DNA methylation biomarkers.

Recent filings

Filing Released Lang Actions
Datum:24.10.2013
Audit Report / Information Classification · 100% confidence The document is a standalone 'Bestätigungsvermerk des Abschlussprüfers' (Auditor's Report) for Epigenomics AG for the fiscal year 2011. It details the scope of the audit, the auditor's opinion, and specific notes regarding the company's going concern status. Since it is a standalone audit report and not the full annual report itself, it falls under the Audit Report category. FY 2011
2013-10-24 German
Datum:22.04.2013
Management Reports Classification · 100% confidence The document is a 'Konzernlagebericht' (Group Management Report) for Epigenomics AG for the fiscal year 2012. It contains detailed management analysis of the economic environment, business strategy, and market outlook. While it is part of the annual reporting package, the text provided is specifically the Management Report (Lagebericht) section, which falls under the 'Management Reports' category.
2013-04-22 German
Datum:18.04.2013
Annual Report Classification · 100% confidence The document is a comprehensive annual financial report for Epigenomics AG for the fiscal year 2012. It includes the auditor's report (Bestätigungsvermerk), the balance sheet (Bilanz), the profit and loss statement (Gewinn- und Verlustrechnung), and the notes to the financial statements (Anhang). This constitutes a full annual report as defined by the 10-K category, which covers company activity and full financial performance. FY 2012
2013-04-18 German
Datum:12.03.2013
Report Publication Announcement Classification · 100% confidence The document is a short notification (under 1,000 characters) that informs investors about the availability of the 2012 Annual Financial Report. It provides a link to the report and specifies the publication date, but does not contain the report itself. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA).
2013-03-12 German
Datum:31.01.2013
Governance Information Classification · 100% confidence The document contains the 'Jahresabschluss' (Annual Financial Statements) for Epigenomics AG for the fiscal year 2010, including the proposal for the appropriation of earnings, the approval by the supervisory board, and the 'Entsprechenserklärung' (Declaration of Conformity) regarding the German Corporate Governance Code. This combination of financial statements and governance disclosures is characteristic of an Annual Report (10-K equivalent in the German context).
2013-01-31 German
Datum:24.04.2012
Audit Report / Information Classification · 98% confidence The document is a formal 'Jahresabschluss' (Annual Financial Statement) for Epigenomics AG for the fiscal year ending December 31, 2011. It contains the balance sheet (Bilanz), profit and loss statement (Gewinn- und Verlustrechnung), and the notes to the financial statements (Anhang). This constitutes the core components of an Annual Report under German HGB accounting standards. While it is a standalone financial statement document, it serves the function of an Annual Report (10-K equivalent in this context). FY 2011
2012-04-24 German

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.